课题基金 / 基金详情

项目摘要

项目成果

ROBERT A FLOYD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Hepatocarcinogenesis is a complex process requiring cell-to-cell interactions within the three-dimensional tissue architecture that constitutes the mammalian liver. We seek to enhance our abilities to investigate hepatocarcinogenesis by extending the process to the culture dish as much as possible. We have developed an organotypic rat liver model in which viable tissue has been maintained in culture for longer than 90 days. The overall objective for this application is to further develop this organotypic culture model for rat liver (and in the future, for human liver tumor tissue, as well), and to demonstrate its usefulness for investigating choline-deficient hepatocarcinogenesis in a rat model. Toward this end, we propose three Specific Aims: (1) For our organotypic rat liver culture model, we will analyze and test all medium components until we arrive at a defined medium that provides long periods of viability as judged by dual vital staining, by gene expression patterns revealed by DNA arrays, by metabolic capabilities revealed by enzyme amounts and activities. (2) We will further characterize CWSV-1 cells, which form islands of tissue in culture that approximate normal liver in pattern of organization, especially as to their ability to give rise to more than one liver cell type and their progression to tumorigenic cells in choline-deficient medium. (3) We will compare and contrast these two culture models in Aims (1) and (2) with respect to the ability of PBN and 4-OH-PBN to increase apoptosis and inhibit tumor development. Ultimately, we seek an organotypic culture model in which the full process of carcinogenesis from tumor initiation through progression to full metastatic cancer can be manipulated and cures tested.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
OMRF MRI SYSTEM: BEHAVIORAL PHARMACOLOGY OF ABUSED DRUG LIKE ALCOHOL, LIVER INJU
OMRF MRI SYSTEM
OMRF MRI SYSTEM: AGING, ALZHEIMER'S DIS, ALS
OMRF MRI SYSTEM: CANCER: LIVER, COLON, E FAECALIS
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: